Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD

• Verfasst von: Kahnert, Kathrin [VerfasserIn]
• Verfasst von: Jörres, Rudolf A. [VerfasserIn]
• Verfasst von: Jobst, Bertram [VerfasserIn]
• Verfasst von: Wielpütz, Mark Oliver [VerfasserIn]
• Verfasst von: Seefelder, Axinja [VerfasserIn]
• Verfasst von: Hackl, Caroline M. [VerfasserIn]
• Verfasst von: Trudzinski, Franziska [VerfasserIn]
• Verfasst von: Watz, Henrik [VerfasserIn]
• Verfasst von: Bals, Robert [VerfasserIn]
• Verfasst von: Behr, Jürgen [VerfasserIn]
• Verfasst von: Rabe, Klaus F. [VerfasserIn]
• Verfasst von: Vogelmeier, Claus F. [VerfasserIn]
• Verfasst von: Alter, Peter [VerfasserIn]
• Verfasst von: Welte, Tobias [VerfasserIn]
• Verfasst von: Herth, Felix [VerfasserIn]
• Verfasst von: Kauczor, Hans-Ulrich [VerfasserIn]
• Verfasst von: Biederer, Jürgen [VerfasserIn]
• Titel: Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD
• Titelzusatz: results from COSYCONET
• Verf.angabe: Kathrin Kahnert, Rudolf A. Jörres, Bertram Jobst, Mark O. Wielpütz, Axinja Seefelder, Caroline M. Hackl, Franziska C. Trudzinski, Henrik Watz, Robert Bals, Jürgen Behr, Klaus F. Rabe, Claus F. Vogelmeier, Peter Alter, Tobias Welte, Felix J. F. Herth, H.U. Kauczor, Jürgen Biederer
• E-Jahr: 2022
• Jahr: 26 October 2022
• Umfang: 9 S.
• Fussnoten: Online veröffentlicht: 18. Oktober 2022, Artikelversion: 26. Oktober 2022 ; Gesehen am 19.12.2023
• Titel Quelle: Enthalten in: Respiratory medicine
• Ort Quelle: Burlington, Mass. : Harcourt, 1999
• Jahr Quelle: 2022
• Band/Heft Quelle: 204(2022), Artikel-ID 107014, Seite 1-9
• ISSN Quelle: 1532-3064
• DOI: doi:10.1016/j.rmed.2022.107014
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1876423633

Abstract

Chronic obstructive pulmonary disease (COPD) is frequently associated with coronary artery disease (CAD). When considering computed tomography (CT) for COPD phenotyping, coronary vessel wall calcification would be a potential marker of cardiac disease. However, non-ECG gated scans as used in COPD monitoring do not comply with established quantitative approaches using ECG-triggered CT and the Agatston score. We studied the diagnostic potential of Agatston scores from non-triggered scans for cardiac disease. The study population was a sub-group of the COPD cohort COSYCONET that underwent CT scanning in addition to comprehensive clinical assessments, echocardiographic data and physician-based diagnoses of comorbidities. Agatston scores from non-contrast enhanced, non-triggered CT were used to identify a cut-off value for CAD via ROC analysis. 399 patients were included (152 female, mean age 66.0 ± 8.2 y). In terms of CAD, an Agatston score ≥1500 AU performed best (AUC 0.765; 95% CI: 0.700, 0.831) and was superior to the conventional cut-off value (400 AU). Using this value for defining groups, there were differences (p < 0.05) in lung function, left atrial diameter and left ventricular end-systolic diameter as well as CT-determined central airway wall thickness pointing towards a bronchitis phenotype. In multivariate analysis, BMI, hyperlipidemia, arterial hypertension, GOLD D (p < 0.05) but particularly Agatston score ≥1500 AU (Odds ratio 10.5; 95% CI: 4.8; 22.6)) were predictors of CAD. We conclude that in COPD patients, Agatston scores derived from non-ECG gated CT showed a much higher cut-off value (1500 AU) for actionable coronary artery disease than the score derived from ECG-triggered CT in cardiology patients.